Published in Cancer Biother Radiopharm on October 01, 2001
Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment. J Immunother (2012) 1.24
Clinical significance of immune cell infiltration within gallbladder cancer. Br J Cancer (2003) 1.21
Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation. Expert Opin Biol Ther (2010) 0.91
Optimization manufacture of virus- and tumor-specific T cells. Stem Cells Int (2011) 0.86
Translational mini-review series on vaccines: Dendritic cell-based vaccines in renal cancer. Clin Exp Immunol (2007) 0.84
Efficient and reproducible generation of tumour-infiltrating lymphocytes for renal cell carcinoma. Br J Cancer (2015) 0.83
Optimizing the production of suspension cells using the G-Rex "M" series. Mol Ther Methods Clin Dev (2014) 0.80
Optimizing the culture of Plasmodium falciparum in hollow fiber bioreactors. Southeast Asian J Trop Med Public Health (2010) 0.78
Two letters cite errors in data in article on the Kern and DiSC assays. Oncology (Williston Park) (1992) 5.12
Human immune response to multiple injections of murine monoclonal IgG. J Immunol (1985) 1.68
A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9L gliosarcoma. J Neurooncol (1994) 1.47
Amino acid sequence of an analogous peptide from two forms of cytochrome P-450. J Biol Chem (1981) 1.43
Sequential re-analysis of a phase-III clinical trial in non-small cell lung cancer. Eur Respir J (2000) 1.38
Pharmacokinetics of 111In-labelled monoclonal antibody ZCE-025 and fragments in tumour-bearing mice. Nucl Med Commun (1995) 1.38
Lead poisoning from a gunshot wound. Report of a case and review of the literature. Am J Med (1979) 1.32
The complete amino acid sequence of rabbit phenobarbital-induced liver microsomal cytochrome P-450. J Biol Chem (1983) 1.18
Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: results of a phase II trial of rituximab. J Clin Oncol (1999) 1.14
The complete amino acid sequence of a constitutive form of liver microsomal cytochrome P-450. J Biol Chem (1985) 1.09
Tumor size: effect on monoclonal antibody uptake in tumor models. J Nucl Med (1986) 1.06
Complete amino acid sequence of steer liver microsomal NADH-cytochrome b5 reductase. J Biol Chem (1985) 1.06
Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukemia. Blood (1982) 1.02
Purification and characterization of avian oligosaccharyltransferase. Complete amino acid sequence of the 50-kDa subunit. J Biol Chem (1994) 1.01
Chemical structure of rat liver cytochrome b5. Isolation of peptides by high-pressure liquid chromatography. Biochim Biophys Acta (1982) 1.00
Immunoincompetence in cancer patients. Assessment by in vitro stimulation tests and quantification of lymphocyte subpopulations. Cancer (1984) 1.00
Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody. J Clin Oncol (1984) 0.98
Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity. Ann Oncol (2004) 0.98
Transduction of human renal carcinoma cells with human gamma-interferon gene via retroviral vector. Cancer Gene Ther (1996) 0.95
Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross-reactivity with an antigen on circulating cells. Cancer Res (1984) 0.94
The covalent structure of hepatic microsomal epoxide hydrolase. II. The complete amino acid sequence. J Biol Chem (1984) 0.91
Establishment of a human B-cell tumor in athymic mice. Cancer Res (1987) 0.91
Applications and limitations of peripheral blood lymphocyte immunoglobulin light chain analysis in the evaluation of non-Hodgkin's lymphoma. Cancer (1985) 0.91
Monoclonal antibody KS1/4-methotrexate immunoconjugate studies in non-small cell lung carcinoma. Am J Respir Crit Care Med (1994) 0.87
Intracranial administrations of single or multiple source allogeneic cytotoxic T lymphocytes: chronic therapy for primary brain tumors. J Neurooncol (1994) 0.87
The covalent structure of rabbit phenobarbital-induced cytochrome P-450. Partial amino acid sequence and order of cyanogen bromide peptides. J Biol Chem (1982) 0.87
Human oligosaccharyltransferase: isolation, characterization, and the complete amino acid sequence of 50-kDa subunit. Arch Biochem Biophys (1995) 0.87
Optimizing the use of rituximab for treatment of B-cell non-Hodgkin's lymphoma: a benefit-risk update. Semin Oncol (2000) 0.86
Problems associated with radioimmunodetection and possibilities for future solutions. J Biol Response Mod (1987) 0.86
Neural differentiation in small round cell tumors of bone and soft tissue with the translocation t(11;22)(q24;q12): an immunohistochemical study of 11 cases. Hum Pathol (1990) 0.84
Renal complications of infectious diseases. Med Clin North Am (1978) 0.83
Phase I clinical comparative study of monoclonal antibody KS1/4 and KS1/4-methotrexate immunconjugate in patients with non-small cell lung carcinoma. Cancer Res (1990) 0.83
Chronic lymphocytic leukemia and other chronic lymphoid proliferations: surface marker phenotypes and clinical correlations. J Clin Oncol (1983) 0.82
Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival. Cancer Immunol Immunother (2010) 0.82
Preclinical trials with combinations and conjugates of T101 monoclonal antibody and doxorubicin. Cancer Res (1986) 0.81
Immune interferon modulation of in vitro murine anti-human T cell monoclonal antibody-mediated cytotoxicity. J Immunol (1986) 0.81
Mechanisms of human CD5 modulation and capping induced by murine monoclonal antibody T101. Clin Immunol Immunopathol (1988) 0.81
Applications of monoclonal antibodies in cancer therapy. Br Med Bull (1984) 0.81
Extracellular paraprotein globules in a patient with monoclonal gammopathy. Arch Pathol Lab Med (1982) 0.81
Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanoma. Cancer Biother Radiopharm (1998) 0.81
Complete remission of nonresectable pancreatic cancer after infusional colloidal phosphorus-32 brachytherapy, external beam radiation therapy, and 5-fluorouracil: a preliminary report. Am J Clin Oncol (1999) 0.80
Statistical approach to immunosuppression classification using lymphocyte surface markers and functional assays. Cancer Res (1983) 0.80
Monoclonal antibodies in the treatment of cancer. Crit Rev Oncol Hematol (1984) 0.80
Radioimmunodetection of melanoma utilizing In-111 96.5 monoclonal antibody: a preliminary report. Radiology (1985) 0.80
Characterization of tumor-infiltrating lymphocytes derived from human tumors for use as adoptive immunotherapy of cancer. J Immunother (1997) 0.80
Short-term tumor cell lines from renal cell carcinoma for use as autologous tumor cell vaccines in the treatment of kidney cancer. Cancer Biother Radiopharm (2000) 0.79
Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma. Crit Rev Oncol Hematol (2001) 0.79
Inhibition of human T-cell tumor growth by T101-ricin A-chain in an athymic mouse model. Cancer Res (1988) 0.79
Cancer cells release a covalent complex containing disulfide-linked domains from urinary plasminogen activator, neural cell adhesion molecule, and haptoglobin alpha and beta chains. Arch Biochem Biophys (1997) 0.79
Migration of activated lymphocytes when adoptively transferred into cannulated rat brain. J Neuroimmunol (1994) 0.79
Alterations of peripheral blood B-lymphocyte populations in plasma cell disorders. Cancer (1981) 0.79
Magic bullets at last! Finally--approval of a monoclonal antibody for the treatment of cancer!!! Cancer Biother Radiopharm (1997) 0.78
Establishment and characterization of an Epstein-Barr virus-negative lymphoma B-cell from a patient with a diffuse large cell lymphoma. Cancer Res (1982) 0.78
Primary lymphoma of the kidney: complete remission after systemic chemotherapy. J Natl Cancer Inst (1993) 0.78
Molecular biotherapy with human monoclonal antibodies. Mol Biother (1988) 0.78
Cancer clinical trials in the community setting: a 20 year retrospective. Cancer Biother (1995) 0.78
Athymic mouse model of a human T-cell tumor. Cancer Res (1985) 0.78
Toxicities and side effects associated with intravenous infusions of murine monoclonal antibodies. J Biol Response Mod (1986) 0.77
Characterization of cancer cell lines established from two human metastatic breast cancers. In Vitro Cell Dev Biol Anim (2000) 0.77
Interleukin-2 induces N-glycosylation in T-cells: characterization of human lymphocyte oligosaccharyltransferase. Biochem Biophys Res Commun (1998) 0.77
Extensive disease small cell carcinoma of the lung: trial of non-cross resistant chemotherapy and consolidation radiotherapy. Cancer (1982) 0.77
In vivo immune restoration in advanced cancer patients after administration of thymosin fraction 5 or thymosin alpha 1. J Biol Response Mod (1983) 0.77
The feasibility of using short-term cultures of ovarian cancer cells for use as autologous tumor cell vaccines as adjuvant treatment of advanced ovarian cancer. Cancer Biother Radiopharm (1999) 0.77
Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancer. Cancer (1993) 0.76
Purification and characterization of hepatic oligosaccharyltransferase. Biochem Mol Biol Int (1995) 0.76
Tissue distribution and serum kinetics of T101 monoclonal antibody during passive anti-cancer therapy. Clin Immunol Immunopathol (1986) 0.76
Radioimmunodetection of cancer with the use of indium-111-labeled monoclonal antibodies. NCI Monogr (1987) 0.76
Calcium-dependent proteolysis of actin during storage of platelet concentrates. Blood (1989) 0.76
Repeated pentostatin (2'deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia. West J Med (1988) 0.75
Bilateral otitis media and hearing loss in an adult. Yale J Biol Med (1986) 0.75
Autologous peripheral blood mononuclear cell recognition of autologous proliferating tumor cells in the context of a patient-specific vaccine trial. J Biomed Biotechnol (2011) 0.75
Utilization of breast-conserving surgery in breast cancer. J Clin Oncol (2001) 0.75
Membranous nephropathy associated with an unusual phenotype of chronic lymphocytic leukemia. Cancer (1983) 0.75
Combination interferon-alpha2a and 13-cis-retinoic acid enhances radiosensitization of human malignant glioma cells in vitro. Clin Cancer Res (1999) 0.75
Characterization of a monoclonal antibody that reacts with activated/proliferating cells and subsets of leukemia cells. J Biol Response Mod (1984) 0.75
Adjuvant adoptive immunotherapy for pediatric recurrent brain tumors. Online J Curr Clin Trials (1993) 0.75
Whither magic bullets and guided missiles: monoclonal antibodies 20 years later. Cancer Biother (1995) 0.75
Acetaminophen overdose: a growing health care hazard. Clin Toxicol (1979) 0.75
Primary tuberculous enteritis: forgotten but not gone. Tex Med (1979) 0.75
Chromosomal translocation in a child with chronic lymphocytic leukemia. N Engl J Med (1984) 0.75
Acetaminophen overdose and hepatic necrosis. Tex Med (1978) 0.75
Induction of in vitro and in vivo antigenic modulation by the anti-human T-cell monoclonal antibody T101. Cancer Res (1984) 0.75
Non-cross-resistant chemotherapy and consolidation radiotherapy for small cell carcinoma of the lung. Cancer Treat Rep (1982) 0.75
Microassay for oligosaccharyltransferase: separation of reaction components by partitioning in detergent solution followed by ultrafiltration. Anal Biochem (1994) 0.75
Thyroxine metabolism by pineal slices. Neuroendocrinology (1971) 0.75
The use of monoclonal antibodies and flow cytometry to detect peripheral blood and bone marrow involvement of a diffuse, poorly differentiated lymphoma. Int J Immunopharmacol (1985) 0.75
Tumor localization by tumor infiltrating lymphocytes labeled with indium-111 in patients with metastatic renal cell carcinoma, melanoma, and colorectal cancer. Cancer Biother Radiopharm (1997) 0.75
Phase II trial of thymosin fraction 5 and thymosin alpha 1. J Biol Response Mod (1987) 0.75
How can we improve survival rate for patients with non-small-cell lung cancer? Clin Lung Cancer (2000) 0.75
Transport mechanisms and thyroxine uptake in pineal slices. Neuroendocrinology (1971) 0.75
Short-term tumor cell lines from breast cancer for use as autologous tumor cell vaccines in the treatment of breast cancer. Cancer Biother Radiopharm (2001) 0.75
Modulation of renal carcinoma cells in vitro: comparison after transduction with retroviral vector containing a human IFN-gamma gene versus incubation with soluble IFN-gamma. J Interferon Cytokine Res (1999) 0.75
Failure of low-dose, total-body irradiation to augment combination chemotherapy in extensive-stage small cell carcinoma of the lung. J Clin Oncol (1983) 0.75
Collagen breakdown and ammonia inhalation. Arch Environ Health (1979) 0.75
Procarbazine, vincristine, CCNU, and cyclophosphamide (POCC) in the treatment of metastatic malignant melanoma. Cancer Treat Rep (1980) 0.75
Continuous infusion of T101 monoclonal antibody in chronic lymphocytic leukemia and cutaneous T-cell lymphoma. J Biol Response Mod (1986) 0.75
The covalent structure of hepatic microsomal epoxide hydrolase. I. Isolation and characterization of the cyanogen bromide fragments. J Biol Chem (1984) 0.75